SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (9322)10/22/2003 2:43:04 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
Ian,

Yes there is optimism and it has appreciated significantly, but their two other drugs have significant sales potential, and at some point I would expect other triptan makers to follow PFE's lead in adding a combo product.

The drugs are safe and efficacious - the key risk is the FDA's distaste for combination drugs.

Peter